Literature DB >> 10100843

The structure of the antimicrobial active center of lactoferricin B bound to sodium dodecyl sulfate micelles.

D J Schibli1, P M Hwang, H J Vogel.   

Abstract

Lactoferricin B (LfcinB) is a 25-residue antimicrobial peptide released from bovine lactoferrin upon pepsin digestion. The antimicrobial center of LfcinB consists of six residues (RRWQWR-NH2), and it possesses similar bactericidal activity to LfcinB. The structure of the six-residue peptide bound to sodium dodecyl sulfate (SDS) micelles has been determined by NMR spectroscopy and molecular dynamics refinement. The peptide adopts a well defined amphipathic structure when bound to SDS micelles with the Trp sidechains separated from the Arg residues. Additional evidence demonstrates that the peptide is oriented in the micelle such that the Trp residues are more deeply buried in the micelle than the Arg and Gln residues.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10100843     DOI: 10.1016/s0014-5793(99)00214-8

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  27 in total

1.  Interactions of the designed antimicrobial peptide MB21 and truncated dermaseptin S3 with lipid bilayers: molecular-dynamics simulations.

Authors:  Craig M Shepherd; Hans J Vogel; D Peter Tieleman
Journal:  Biochem J       Date:  2003-02-15       Impact factor: 3.857

2.  Structure-function analysis of tritrpticin analogs: potential relationships between antimicrobial activities, model membrane interactions, and their micelle-bound NMR structures.

Authors:  David J Schibli; Leonard T Nguyen; Stephanie D Kernaghan; Øystein Rekdal; Hans J Vogel
Journal:  Biophys J       Date:  2006-09-22       Impact factor: 4.033

3.  Production of stable isotope enriched antimicrobial peptides in Escherichia coli: an application to the production of a 15N-enriched fragment of lactoferrin.

Authors:  A Majerle; J Kidric; R Jerala
Journal:  J Biomol NMR       Date:  2000-10       Impact factor: 2.835

4.  Human lactoferricin is partially folded in aqueous solution and is better stabilized in a membrane mimetic solvent.

Authors:  Howard N Hunter; A Ross Demcoe; Håvard Jenssen; Tore J Gutteberg; Hans J Vogel
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

5.  Solution structure of a novel tryptophan-rich peptide with bidirectional antimicrobial activity.

Authors:  Shu-Yi Wei; Jiun-Ming Wu; Yen-Ya Kuo; Heng-Li Chen; Bak-Sau Yip; Shiou-Ru Tzeng; Jya-Wei Cheng
Journal:  J Bacteriol       Date:  2006-01       Impact factor: 3.490

6.  Identification of novel hexapeptides bioactive against phytopathogenic fungi through screening of a synthetic peptide combinatorial library.

Authors:  Belén López-García; Enrique Pérez-Payá; Jose F Marcos
Journal:  Appl Environ Microbiol       Date:  2002-05       Impact factor: 4.792

7.  Serum stabilities of short tryptophan- and arginine-rich antimicrobial peptide analogs.

Authors:  Leonard T Nguyen; Johnny K Chau; Nicole A Perry; Leonie de Boer; Sebastian A J Zaat; Hans J Vogel
Journal:  PLoS One       Date:  2010-09-10       Impact factor: 3.240

8.  A genomic approach highlights common and diverse effects and determinants of susceptibility on the yeast Saccharomyces cerevisiae exposed to distinct antimicrobial peptides.

Authors:  Belén López-García; Mónica Gandía; Alberto Muñoz; Lourdes Carmona; Jose F Marcos
Journal:  BMC Microbiol       Date:  2010-11-15       Impact factor: 3.605

9.  Beta-sheet pore-forming peptides selected from a rational combinatorial library: mechanism of pore formation in lipid vesicles and activity in biological membranes.

Authors:  Joshua M Rausch; Jessica R Marks; Ramesh Rathinakumar; William C Wimley
Journal:  Biochemistry       Date:  2007-10-06       Impact factor: 3.162

10.  Synthetic molecular evolution of pore-forming peptides by iterative combinatorial library screening.

Authors:  Aram J Krauson; Jing He; Andrew W Wimley; Andrew R Hoffmann; William C Wimley
Journal:  ACS Chem Biol       Date:  2013-02-20       Impact factor: 5.100

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.